Compare
Cosmos Health Inc. vs Stemtech Corp vs Nu Skin Enterprises, Inc. vs HWH International Inc.
| Latest fiscal year | Cosmos Health Inc. COSM | Stemtech Corp STEK | Nu Skin Enterprises, Inc. NUS | HWH International Inc. ESYN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $65.27M | $2.88M | $1.49B | $866.9K |
| Revenue growth (YoY) | +19.9% | -43.1% | -14.3% | -30.8% |
| Gross margin | 12.1% | 80.3% | 69.4% | 53.0% |
| Operating margin | -25.6% | -94.2% | 4.4% | n/a |
| Net margin | -29.3% | -140.7% | 10.8% | -303.4% |
| Net income | -$19.14M | -$4.05M | $160.20M | -$2.63M |
| EPS (Diluted) | -$0.63 | -$0.02 | $3.18 | -$0.40 |
| Operating cash flow | -$8.45M | -$483.6K | $80.29M | -$1.75M |
| Free cash flow | -$8.50M | -$483.6K | $46.01M | -$1.77M |
| Cash & equivalents | $715.7K | n/a | $238.63M | $2.09M |
| Total assets | $65.48M | $3.15M | $1.41B | $4.57M |
| Total liabilities | $47.05M | $10.59M | $600.07M | n/a |
| Shareholders' equity | $18.42M | -$6.96M | $805.24M | $2.62M |
| Return on year-end equity | -103.9% | n/a | 19.9% | -100.4% |
| Shares outstanding | 41.07M | 425.98M | n/a | 7.48M |
Revenue, most recent five fiscal years
| Fiscal year | Cosmos Health Inc. | Stemtech Corp | Nu Skin Enterprises, Inc. | HWH International Inc. |
|---|---|---|---|---|
| Latest | $65.27M Ended 2025-12-31 | $2.88M Ended 2025-12-31 | $1.49B Ended 2025-12-31 | $866.9K Ended 2025-12-31 |
| 1 year earlier | $54.43M Ended 2024-12-31 | $5.05M Ended 2024-12-31 | $1.73B Ended 2024-12-31 | $1.25M Ended 2024-12-31 |
| 2 years earlier | $53.38M Ended 2023-12-31 | $4.92M Ended 2023-12-31 | $1.97B Ended 2023-12-31 | $830.5K Ended 2023-12-31 |
| 3 years earlier | $50.35M Ended 2022-12-31 | $4.56M Ended 2022-12-31 | $2.23B Ended 2022-12-31 | n/a |
| 4 years earlier | $56.24M Ended 2021-12-31 | $4.32M Ended 2021-12-31 | $2.70B Ended 2021-12-31 | n/a |